1. Copstead-Kirkhorn LEC, Banasik JL. Study Guide for Copstead and Banasik Pathophysiology. 4th ed. St. Louis, MO: Saunders Elsevier; 2010.
2. Nowak T, Gordon Hanford A. Pathophysiology: Concepts and Applications for Health Care Professionals. 3rd ed. New York, NY: McGraw-Hill; 2004.
3. Hall JE. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016.
4. Grossman S, Porth CM. Porth's Pathophysiology: Concepts of Altered Health States. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014.
5. Bruyere HJ. 100 Case Studies in Pathophysiology. 1st ed. Baltimore, MD: Lippincott Williams & Wilkins; 2009.
6. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 8th ed. St. Louis, MO: Elsevier; 2019.
7. Dembic Z. The Cytokines of the Immune System: The Role of Cytokines in Disease Related to Immune Response. San Diego, CA: Academic Press; 2015.
8. Zouali M. The Epigenetics of Autoimmune Diseases. 1st ed. Hoboken, NJ: John Wiley & Sons; 2009.
9. Mitchell RN, Kumar V, Fausto N, Abbas AK, Aster JC. Pocket Companion to Robbins & Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Elsevier; 2017.
10. Huether SE, McCance KL. Understanding Pathophysiology. 6th ed. St. Louis, MO: Elsevier; 2017.
11. Rose NR, Mackay IR. The Autoimmune Diseases. 5th ed. San Diego, CA: Academic Press; 2014.
12. Bullock BL, Henze RL. Focus on Pathophysiology. Philadelphia, PA: Lippincott Williams and Wilkins; 2000.
13. Corwin EJ. Handbook of Pathophysiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
14. Price SA, Wilson LM. Pathophysiology: Clinical Concepts of Disease Processes. 6th ed. Maryland Heights, MO: Mosby; 2002.
15. Mahmoudi M. Challenging Cases in Rheumatology and Diseases of the Immune System. New York, NY: Springer; 2013.
16. American Medical Association. The American Medical Association: Essential Guide to Asthma. New York, NY: Pocket Books; 1998.
17. Velasquez-Manoff M. An Epidemic of Absence: A New Way of Understanding Allergies and Autoimmune Diseases. New York, NY: Scribner; 2012.
18. Upton E. Sorting Out Autoimmune Disease: Your Roadmap to Wellness, Naturally. Beverly Hills, CA: Fifth Element Press; 2018.
19. Weil A. The Autoimmune Solution: Learn How to Prevent and Overcome Inflammatory Disease. Scotts Valley, CA: CreateSpace Independent Publishing; 2015.
20. Markovchick VJ, Pons PT, Bakes KA. Emergency Medicine Secrets. 5th ed. St. Louis, MO: Elsevier; 2011.
21. Langwith J. Perspectives on Diseases & Disorders: Autoimmune Disease. Farmington Hills, MI: Greenhaven Press; 2011.
22. Aaseng N. Autoimmune Diseases. London: Franklin Watts; 1995.
23. Gulanick M, Myers JL. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 9th ed. St. Louis, MO: Elsevier; 2017.
24. O'Bryan T. The Autoimmune Fix: How to Stop the Hidden Autoimmune Damage That Keeps You Sick, Fat, and Tired Before It Turns Into Disease. Emmaus, PA: Rodale; 2016.
26. Merck Manual. Asthma. Available at https://www.merckmanuals.com/professional/pulmonary-disorders/asthma-and-related-disorders/asthma. Last accessed October 22, 2019.
27. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. Available at https://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf. Last accessed October 22, 2019.
28. Smith AD, Cowan JO, Brassett, KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment of chronic asthma. N Engl J Med. 2005;352(21):2163-2172.
29. Ackley BJ, Ladwig GB, Makic MF. Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care. 11th ed. St. Louis, MO: Elsevier; 2017.
30. Alexander L. Autoimmune Diseases. Roseville, CA: NetCE; 2017.
31. Colbert D. The Bible Cure for Autoimmune Diseases. Lake Mary, FL: Siloam; 2004.
32. Ignatavicius DD, Workman ML. Medical-Surgical Nursing: Patient-Centered Collaborative Care. 8th ed. St. Louis, MO: Elsevier; 2016.
33. Bope ET, Kellerman RD. Conn's Current Therapy 2017. 1st ed. Philadelphia, PA: Elsevier; 2017.
34. Mansoor DK, Sharma HP. Clinical presentations of food allergy. Pediatr Clin N Am. 2011;58:315-326.
35. Burks W. Skin manifestations of food allergy. Pediatrics. 2003;111(6 Pt 3):1617-1624.
36. Cleveland Clinic. Urticaria (Hives) and Angioedema. Available at https://my.clevelandclinic.org/health/diseases/8630-urticaria-hives-and-angioedema. Last accessed October 21, 2019.
37. LexiComp Online. Available at https://online.lexi.com. Last accessed October 21, 2019.
38. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117(2):391-397.
39. Simons FE, Ardusso LR, Bilò MB, et al. World allergy organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011;127(3):587-593.
40. Campbell RL, Hagan JB, Manivannan V, et al. Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012;129(3):748-752.
41. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003;111(6 pt 3):1601-1608.
42. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis—a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384.
43. Chipps BE. Update in pediatric anaphylaxis: a systematic review. Clin Pediatr (Phila). 2013;52(5):451-461.
44. Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):S1-S58.
45. Ross MP, Ferguson M, Street D, Klontz K, Schroeder T, Luccioli S. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol. 2008;121(1):166-171.
46. Rudders SA, Banerji A, Clark S, Camargo Jr CA. Age-related differences in the clinical presentation of food-induced anaphylaxis.J Pediatr. 2011;158(2):326-328.
47. Simons FE, Ardusso LR, Bilò MB, et al. 2012 update: world allergy organization guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12(4):389-399.
48. Prince BT, Mikhail I, Stukus DR. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy. 2018;11:143-151.
49. Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122(6):1161-1165.
50. Lieberman P, Camargo Jr CA, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma, and Immunology epidemiology of anaphylaxis working group. Ann Allergy Asthma Immunol. 2006;97(5):596-602.
51. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol. 2006;97(1):39-43.
52. Järvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol. 2008;122(1):133-138.
53. Russell WS, Farrar JR, Nowak R, et al. Evaluating the management of anaphylaxis in U.S. emergency departments: guidelines vs. practice. World J Emerg Med. 2013;4(2):98-106.
54. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol. 2002;110(2 Suppl):S64-S69.
55. Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev. 2012;(4):CD007596.
56. Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009;64(2):204-212.
57. Campbell RL, Li JT, Nicklas RA, Sadosty AT, Members of the Joint Task Force, Practice Parameter Workgroup. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599-608.
58. Gupta RS, Springston EE, Warrier MR, et al. The prevelance, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011;128(1):e9-e17.
59. Acker WW, Plasek JM, Blumenthal KG, et al. Prevalence of food allergies and intolerances documented in electronic health records. J Allergy Clin Immunol. 2017;140(6):1587-1591.
60. Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997–2011. NCHS Data Brief. 2013;(121):1-8.
61. Gupta R, Warren C, Blumenstock J, Kotowska J, Mittal K, Smith B. OR078 The prevalence of childhood food allergy in the United States: an update. Ann Allergy Asthma Immunol. 2017;119(5):S11.
62. Centers for Disease Control and Prevention. National Health Interview Survey. Available at https://www.cdc.gov/nchs/nhis/shs/tables.htm. Last accessed October 22, 2019.
63. Food Allergy Research & Education. Facts and Statistics. Available at https://www.foodallergy.org/life-with-food-allergies/food-allergy-101/facts-and-statistics. Last accessed October 22, 2019.
64. Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5(5):1169-1178.
65. Patel DA, Holdford DA, Edwards E, Carroll NV. Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States. J Allergy Clin Immunol. 2011;128(1):110-115.
66. Burks AW, Tang M, Sicherer S, et al. ICON: food allergy. J Allergy Clin Immunol. 2012;129(4):906-920.
67. Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2010;126(4):798-806.
68. Sicherer SH, Wood RA, American Academy of Pediatrics Section on Allergy and Immunology. Allergy testing in childhood: using allergen-specific IgE tests. Pediatrics. 2012;129(1):193-197.
69. Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology. 2005;128(4):1089-1113.
70. Mayer L. Mucosal immunity. Pediatrics. 2003;111(6 pt 3):1595-1600.
71. Fleischer DM, Perry TT, Atkins D, et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130(1):25-32.
72. Gupta RS, Warren CM, Smith BM, et al. Prevalence and severity of food allergies among U.S. adults. JAMA Netw Open. 2019;2(1):e185630.
73. Gupta RS, Springston EE, Smith B, Pongracic J, Holl JL, Warrier MR. Parent report of physician diagnosis in pediatric food allergy. J Allergy Clin Immunol. 2013;131(1):150-156.
74. Vargas PA, Sicherer SH, Christie L, et al. Developing a food allergy curriculum for parents. Pediatr Allergy Immunol. 2011;22(6):575-582.
75. Eigenmann PA, Zamora SA. An Internet-based survey on the circumstances of food-induced reactions following the diagnosis of IgE-mediated food allergy. Allergy. 2002;57(5):449-453.
76. Kim JS, Sicherer SH. Living with food allergy: allergen avoidance. Pediatr Clin North Am. 2011;58(2):459-470.
77. Steinman HA. "Hidden" allergens in foods. J Allergy Clin Immunol. 1996;98(2):241-250.
78. Centers for Disease Control and Prevention. FastStats: Asthma. Available at https://www.cdc.gov/nchs/fastats/asthma.htm. Last accessed October 22, 2019.
79. McMillan JA, Feigin RD, DeAngelis C, Jones Jr MD. Oski's Pediatrics: Principles and Practice. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
80. National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Available at https://www.nhlbi.nih.gov/sites/default/files/media/docs/asthgdln_1.pdf. Last accessed October 22, 2019.
81. BlueCross BlueShield of Texas. 2018 Clinical Practice Guidelines: Asthma. Available at https://www.bcbstx.com/provider/pdf/asthma_cpg_2018.pdf. Last accessed October 22, 2019.
82. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2018 Update). Available at https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf. Last accessed October 22, 2019.
83. Centers for Disease Control and Prevention. Common Asthma Triggers. Available at https://www.cdc.gov/asthma/triggers.html. Last accessed October 22, 2019.
84. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising? Results from Olmstead County, Minnesota, 1955–2007. Arthritis Rheum. 2010;62(6):1576-1582.
85. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005;72(6):1037-1047.
86. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Firstein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR (eds). Kelley and Firestein's Textbook of Rheumatology. 10th ed. Philadelphia, PA: Elsevier; 2017: 1115-1166.
87. Goldring SR. A 55-year-old woman with rheumatoid arthritis. JAMA. 2000;283(4):524-531.
88. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580-1588.
89. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Rheumatoid Arthritis. Available at https://www.niams.nih.gov/health-topics/rheumatoid-arthritis. Last accessed October 22, 2019.
90. O'Dell J. Rheumatoid arthritis. In: Goldman L, Schafer AI (eds). Goldman-Cecil Medicine. 25th ed. New York, NY: Elsevier; 2015.
91. Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960-977.
92. Jurgens MS, Welsing PM, Jacobs JW. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S56-S63.
93. Singh JA, Saag KG, Bridges Jr SL, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1-26.
94. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med. 2007;146(6):406-415.
95. Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple disease-modifying antirheumatic drigs in rheumatoid arthritis: a preventive strategy. Ann Intern Med. 1999;131(10):768-774.
96. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med. 2004;350(21):2167-2179.
97. Wells G, Li T, Maxwell L, MacLean R, Tugwell P. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. J Rheumatol. 2007;34(2):280-289.
98. van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum. 1996;39(1):34-40.
99. Falvo D, Holland BE. Medical and Psychosocial Aspects of Chronic Illness and Disability. 6th ed. Burlington, MA: Jones & Bartlett Learning; 2017.
100. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases. Lupus: A Patient Care Guide for Nurses and Other Health Professionals. Bethesda, MD: The Institute; 2006.
101. Wallace DJ. The Lupus Book: A Guide for Patients and Their Families. 6th ed. New York, NY: Oxford; 2019.
102. Phillips RH. Coping with Lupus: A Practical Guide to Alleviating the Challenges of Systemic Lupus Erythematosus. New York, NY: Penguin Group; 2012.
103. Mayo Clinic. Lupus. Available at https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789. Last accessed October 22, 2019.
104. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Systemic Lupus Erythematosus (Lupus). Available at https://www.niams.nih.gov/health-topics/lupus. Last accessed October 22, 2019.
105. Medscape. Drug-Induced Lupus Erythematosus. Available at https://emedicine.medscape.com/article/1065086-overview. Last accessed October 22, 2019.
106. Lupus Foundation of America. Lab Tests for Lupus. Available at https://www.lupus.org/resources/lab-tests-for-lupus. Last accessed October 22, 2019.
107. Lab Tests Online. Complement. Available at https://labtestsonline.org/tests/complement. Last accessed October 22, 2019.
108. U.S. Food and Drug Administration. FDA Approves First Treatment for Pediatric Patients with Lupus. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-pediatric-patients-lupus. Last accessed October 22, 2019.
109. Collins CE, Dall'Era M, Kan H, et al. Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA. Lupus Sci Med. 2016;3(1):e000118.
110. Touma Z, Sayani A, Pineau CA, et al. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study. Rheumatol Int. 2017;37(6):865-873.
111. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164(12):1275-1284.
112. Garcia-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280.
113. Al-Hashimi I, Khuder S, Haghighat N, Zipp M. Frequency and predictive value of the clinical manifestations in Sjögren syndrome. J Oral Pathol Med. 2001;30(1):1-6.
114. Harboe E, Tjensvoll AB, Maroni S, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Ann Rheum Dis. 2009;68(10):1541-1546.
115. Mellgren SI, Göransson LG, Omdal R. Primary Sjögren syndrome associated neuropathy. Can J Neurol Sci. 2007;34(3):280-287.
116. Sánchez-Guerrero J, Pérez-Dosal MR, Cárdenas-Velázquez F, et al. Prevalence of Sjögren syndrome in ambulatory patients according to the American-European Consensus Group criteria. Rheumatology. 2005;44(2):235-240.
117. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452-460.
118. American Academy of Ophthalmology. Dry Eye Syndrome PPP-2018. Available at https://www.aao.org/preferred-practice-pattern/dry-eye-syndrome-ppp-2018. Last accessed October 22, 2019.
119. Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009;79(6):465-470.
120. Ship JA. Diagnosing, managing, and preventing salivary gland disorders. Oral Dis. 2002;8(2):77-89.
121. Singh JA, Guyatt G, Ogdie A, et al. Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):5-32.
122. Ward MM, Deodhar A, Akl EA, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282-298.
123. Gerson C. Healing "Auto-Immune" Diseases: The Gerson Way. Carmel, CA: Gerson Health Media; 2017.
124. Genetic and Rare Diseases Information Center. Behçet Disease. Available at https://rarediseases.info.nih.gov/diseases/848/behcet-disease. Last accessed October 21, 2019.
125. Genetic and Rare Diseases Information Center. Kawasaki Disease. Available at https://rarediseases.info.nih.gov/diseases/6816/kawasaki-disease. Last accessed October 21, 2019.
126. International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia.2013;33(9):629-808.
127. Medscape. Giant Cell Arteritis (Temporal Arteritis). Available at https://emedicine.medscape.com/article/332483-overview. Last accessed October 22, 2019, 2019.
128. Carter J. Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks. Available at http://www.jasoncartermd.com/resources/pdf/Migraine%20Guidelines.pdf. Last accessed October 22, 2019.
129. Centers for Disease Control and Prevention. Lyme Disease: Data and Surveillance. Available at https://www.cdc.gov/lyme/datasurveillance/index.html. Last accessed October 22, 2019.
130. Semantic Scholar. Will There Ever Be An Accurate Test for Lyme Disease? Available at https://pdfs.semanticscholar.org/a964/f1f40b94ea9ff1f8d5eef865d27f174e470b.pdf. Last accessed October 22, 2019.
131. Lin T, Oliver JH Jr, Gao L, Kollars TM Jr, Clark KL. Genetic heterogeneity of Borrelia burgdorferi sensu lato in the southern United States based on restriction fragment length polymorphism and sequence analysis. J Clin Microbiol. 2001;39(7):2500-2507.
132. WebMD. New Lyme Disease Bacteria Discovered: CDC. Available at https://www.webmd.com/arthritis/news/20160209/new-lyme-disease-bacteria-discovered-in-upper-midwest-cdc. Last accessed October 22, 2019.
133. Steere AC. A 58-year old man with a diagnosis of chronic Lyme disease. JAMA. 2002;288(8):1002-1010.
134. Spielman A, Wilson ML, Levine JF, Piesman J. Ecology of Ixodes dammini-borne human babesiosis and lyme disease. Annu Rev Entomol. 1985;30:439-460.
135. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004;113(8):1093-1101.
136. DePietopaolo DL, Powers JH, Gill JM, Foy AJ. Diagnosis of Lyme disease. Am Fam Physician. 2005;72(2):297-304.
137. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2007;69(1):91-102.
138. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med. 1988;319(22):1441-1446.
139. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135.
140. Volpe R. Autoimmune Diseases of the Endocrine System. Boca Raton, FL: CRC Press; 1990.
141. Centers for Disease Control and Prevention. HIV Surveillance Report. Volume 29. Available at https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf. Last accessed October 22, 2019.
142. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. Available at https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Last accessed October 22, 2019.
143. Centers for Disease Control and Prevention. Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014: Summary for Clinical Providers. Available at https://stacks.cdc.gov/view/cdc/44065. Last accessed October 22, 2019.
144. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368(9534):489-504.
145. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33-39.
146. 146.U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Available at https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-. Last accessed October 22, 2019.
147. INSIGHT START Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807.
148. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808-822.
149. Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR. 2009;58(RR):1-207.
150. Gulanick M, Myers JL. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 9th ed. St. Louis, MO: Elsevier; 2017.
151. Ladwig GB, Ackley BJ, Flynn Makic MB. Mosby's Guide to Nursing Diagnosis. 5th ed. St. Louis, MO: Elsevier; 2017.
152. LeMone PT, Burke KM. Medical-Surgical Nursing: Critical Thinking in Client Care. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2007.
153. National Institute of Allergy and Infectious Diseases. Disorders of the Immune System. Available at https://www.niaid.nih.gov/research/immune-system-disorders. Last accessed October 21, 2019.
154. American Academy of Allergy, Asthma, and Immunology. Primary Immunodeficiency Disease. Available at https://www.aaaai.org/conditions-and-treatments/primary-immunodeficiency-disease. Last accessed October 21, 2019.
155. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest. 1992;101:1644-1655.
156. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530-538.
157. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for managing sepsis and septic shock 2016. Intensive Care Med. 2017;43(3):304-377.
158. Society of Critical Care Medicine. SSC Hour-1 Bundle. Available at http://www.survivingsepsis.org/Bundles. Last accessed October 21, 2019.
1. Nicholson PJ, Cullinan P, Burge PS, Boyle C. Occupational Asthma: Prevention, Identification and Management: Systematic Review and Recommendations. London: British Occupational Health Research Foundation; 2010. Available at https://www.bohrf.org.uk/downloads/OccupationalAsthmaEvidenceReview-Mar2010.pdf. Last accessed October 25, 2019.
2. Jacobson JA, Roberts CC, Bencardino JT, et al. ACR Appropriateness Criteria: Chronic Extremity Joint Pain, Suspected Inflammatory Arthritis. Reston, VA: American College of Radiology; 2016. Available at https://acsearch.acr.org/docs/3097211/Narrative. Last accessed October 25, 2019.
3. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797-808. Available at https://www.rheumatology.org/Portals/0/Files/ACR%20Guidelines%20for%20Screening,%20Treatment,%20and%20Management%20of%20Lupus%20Nephritis.pdf. Last accessed October 25, 2019.
4. Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):5-32. Available at https://www.rheumatology.org/Portals/0/Files/PsA-Guideline-2018.pdf. Last accessed October 25, 2019.
5. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135. Available at https://www.tandfonline.com/doi/full/10.1586/14787210.2014.940900. Last accessed October 25, 2019.
6. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Bethesda, MD: Department of Health and Human Services; 2016. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Last accessed October 25, 2019.
7. National Guideline Centre. Sepsis: Recognition, Diagnosis and Early Management. London: National Institute for Health and Care Excellence; 2016. Available at https://www.nice.org.uk/guidance/ng51. Last accessed October 25, 2019.